Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.73% | 88.46% | 80.39% | 80.88% | -17.31% |
| Total Depreciation and Amortization | -98.72% | -98.67% | -35.14% | -36.71% | 0.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -166.23% | -172.45% | -9.91% | -12.12% | -219.20% |
| Change in Net Operating Assets | -95.20% | -95.09% | -- | -- | 7,259.18% |
| Cash from Operations | 51.50% | 50.38% | 97.43% | 97.49% | 30.41% |
| Capital Expenditure | -- | -- | -- | -- | 45.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 100.00% | 449.37% | 443.75% | 45.22% |
| Total Debt Issued | -50.00% | -50.00% | -91.20% | -91.20% | -- |
| Total Debt Repaid | 89.80% | 89.80% | -- | -- | 37.32% |
| Issuance of Common Stock | 58.64% | 58.64% | -- | -- | 70,257.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.51% | 30.51% | -- | -- | -- |
| Cash from Financing | 49.36% | 52.83% | -89.26% | -89.54% | 434.16% |
| Foreign Exchange rate Adjustments | 136.45% | 137.38% | -70.53% | -71.43% | -119.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,110.16% | 1,133.15% | 103.84% | 103.75% | 94.49% |
